Tissue Diseases. Mayo Clin Proc. 2019 Feb;94(2):309-325. \[[PubMed: 30558827](https://pubmed.ncbi.nlm.nih.gov/30558827)\] 5. Kalchiem-Dekel O, Galvin JR, Burke AP, Atamas SP, Todd NW. Interstitial Lung Disease and Pulmonary Fibrosis: A Practical Approach for General Medicine Physicians with Focus on the Medical History. J Clin Med. 2018 Nov 24;7(12) \[[PMC free article: PMC6306719](/pmc/articles/PMC6306719/)\] \[[PubMed: 30477216](https://pubmed.ncbi.nlm.nih.gov/30477216)\] 6. Schwaiblmair M, Behr W, Haeckel T, Märkl B, Foerg W, Berghaus T. Drug induced interstitial lung disease. Open Respir Med J. 2012;6:63-74. \[[PMC free article: PMC3415629](/pmc/articles/PMC3415629/)\] \[[PubMed: 22896776](https://pubmed.ncbi.nlm.nih.gov/22896776)\] 7. Skeoch S, Weatherley N, Swift AJ, Oldroyd A, Johns C, Hayton C, Giollo A, Wild JM, Waterton JC, Buch M, Linton K, Bruce IN, Leonard C, Bianchi S, Chaudhuri N. Drug-Induced Interstitial Lung Disease: A Systematic Review. J Clin Med. 2018 Oct 15;7(10) \[[PMC free article: PMC6209877](/pmc/articles/PMC6209877/)\] \[[PubMed: 30326612](https://pubmed.ncbi.nlm.nih.gov/30326612)\] 8. Capron F. [New classification of interstitial lung disease]. Rev Pneumol Clin. 2005 Jun;61(3):133-40. \[[PubMed: 16142185](https://pubmed.ncbi.nlm.nih.gov/16142185)\] 9. Raghu G, Nyberg F, Morgan G. The epidemiology of interstitial lung disease and its association with lung cancer. Br J Cancer. 2004 Aug;91 Suppl 2(Suppl 2):S3-10. \[[PMC free article: PMC2750810](/pmc/articles/PMC2750810/)\] \[[PubMed: 15340372](https://pubmed.ncbi.nlm.nih.gov/15340372)\] 10. Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994 Oct;150(4):967-72. \[[PubMed: 7921471](https://pubmed.ncbi.nlm.nih.gov/7921471)\] 11. Suki B, Stamenović D, Hubmayr R. Lung parenchymal mechanics. Compr Physiol. 2011 Jul;1(3):1317-51. \[[PMC free article: PMC3929318](/pmc/articles/PMC3929318/)\] \[[PubMed: 23733644](https://pubmed.ncbi.nlm.nih.gov/23733644)\] 12. Ryu JH, Olson EJ, Midthun DE, Swensen SJ. Diagnostic approach to the patient with diffuse lung disease. Mayo Clin Proc. 2002 Nov;77(11):1221-7; quiz 1227. \[[PubMed: 12440558](https://pubmed.ncbi.nlm.nih.gov/12440558)\] 13. Jakubczyc A, Neurohr C. [Diagnosis and Treatment of Interstitial Lung Diseases]. Dtsch Med Wochenschr. 2018 Dec;143(24):1774-1777. \[[PubMed: 30508858](https://pubmed.ncbi.nlm.nih.gov/30508858)\] 14. Raghu G, Brown KK. Interstitial lung disease: clinical evaluation and keys to an accurate diagnosis. Clin Chest Med. 2004 Sep;25(3):409-19, v. \[[PubMed: 15331183](https://pubmed.ncbi.nlm.nih.gov/15331183)\] 15. Kondoh Y, Taniguchi H, Yokoi T, Nishiyama O, Ohishi T, Kato T, Suzuki K, Suzuki R. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia. Eur Respir J. 2005 Mar;25(3):528-33. \[[PubMed: 15738299](https://pubmed.ncbi.nlm.nih.gov/15738299)\] 16. Cottin V, Wollin L, Fischer A, Quaresma M, Stowasser S, Harari S. Fibrosing interstitial lung diseases: knowns and unknowns. Eur Respir Rev. 2019 Mar 31;28(151) \[[PMC free article: PMC9489101](/pmc/articles/PMC9489101/)\] \[[PubMed: 30814139](https://pubmed.ncbi.nlm.nih.gov/30814139)\] 17. Kolb M, Vašáková M. The natural history of progressive fibrosing interstitial lung diseases. Respir Res. 2019 Mar 14;20(1):57. \[[PMC free article: PMC6417262](/pmc/articles/PMC6417262/)\] \[[PubMed: 30871560](https://pubmed.ncbi.nlm.nih.gov/30871560)\] 18. Sciriha A, Lungaro-Mifsud S, Fsadni P, Scerri J, Montefort S. Pulmonary